Web Images Videos Maps News Shopping Gmail more »
Sign in 
Go to Google News Home 
  Advanced archive search
  Archive search help
 News Archives   News Articles - Timeline   Results 1 - 10 of about 110 for diovan + reduce + cardiovascular. (0.17 seconds) 
« View recent news results for diovan reduce cardiovascular
2002  Search other dates

CHAPTER 1 NEWS HEADLINES: CARDIAC DISEASE
$240.00 - DATAMONITOR - Alacra Store - May 1, 2002
In preclinical studies investigating the possibility that antibiotics could reduce. cardiovascular events in heart attack patients who also have had a ...
Related web pages

… BLOOD PRESSURE TREATMENT DIOVAN FOR HEART FAILURE.
Free with registration - AsiaPulse News - AccessMyLibrary.com - Aug 15, 2002
Heart failure is the fastest growing cardiovascular disease in the world ... "Now, US physicians can also prescribe Diovan to improve outcomes and reduce ...
Related web pages

CHAPTER 1 R&D UPDATE
$640.00 - DATAMONITOR - Alacra Store - Oct 1, 2002
Diovan represents a therapeutic advance in the treatment of heart failure as the first ... help reduce the risk of cardiovascular problems. ...
Related web pages

CHAPTER 1 CARDIO UPDATE
$640.00 - DATAMONITOR - Alacra Store - Oct 1, 2002
Diovan represents a therapeutic advance in the treatment of heart failure as the first ... help reduce the risk of cardiovascular problems. ...
Related web pages

FDA approves blood pressure treatment for additional indication.
Free with registration - Biotech Week - AccessMyLibrary.com - Oct 2, 2002
"Now, physicians can also prescribe Diovan to improve outcomes and reduce suffering of their heart failure patients. This important new indication reflects ...
Related web pages

… INDIA TO LAUNCH TWO CARDIOVASCULAR PRODUCTS (Diovan and …
Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com - Jul 6, 2002
It is a low potency statin drug. The company also proposes to introduce Stalix, a Type-II diabetes drug, in early 2003. NIL plans to revitalise its Voveran, ...
Related web pages

Switzerland company: Novartis beats second-quarter expectations
$34.00 - EIU Country Analysis - Alacra Store - Jul 22, 2002
The growth in pharma sales continued to be driven by oncology and cardiovascular drugs. Sales of Novartis's top-selling drug, Diovan, which is used for ...
Swiss Drug Maker Has Profit and Big Hopes for a... - New York Times
All 4 related - Related web pages

CHAPTER STRATEGIC FOCUS
$440.00 - DATAMONITOR - Alacra Store - Feb 18, 2002
(valsartan) reduce or delay the development of type 2 diabetes and cardiovascular. disease in people who have impaired glucose tolerance and are at high.
Related web pages

NEW DATA SHOWS DIOVAN COST-EFFECTIVE IN TREATING HEART …
Free with registration - AsiaPulse News - AccessMyLibrary.com - Sep 3, 2002
"Novartis is also studying the cost-efficacy of Diovan in other diseases spanning the cardiovascular continuum as part of our major ongoing clinical trial ...
Heart failure treatment: what role for ARBs?... - Consultant - ECNext ($4.95)
All 3 related - Related web pages

LIFETIME HEART FAILURE RISK ONE IN FIVE | Article from United Press …
Pay-Per-View - United Press International - HighBeam Research - Nov 4, 2002
Cardiovascular illness is the number one killer of American women. ... Article: FDA APPROVES BLOOD PRESSURE TREATMENT DIOVAN FOR HEART FAILURE. ...
Related web pages






Dates associated with search results are estimated and are determined automatically by a computer program.
 


Google Home - About Google - About News archive search

©2009 Google